Crossmark

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA)

Crossref DOI link: https://doi.org/10.1186/s13063-024-08443-9

Published Online: 2024-09-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Owusu-kyei, Kwabena https://orcid.org/0009-0006-3733-7936
Chen, Haily

Chileshe, Maureen

Quintó, Llorenç

Sibley, Maya

Figueroa-Romero, Antía

Llach, Mireia

Ramírez, Máximo

Bofill, Andreu

Samai, Mohamed

Menéndez, Clara

,
Funding

Funding for this research was provided by:

Grand Challenges in Global Health (OPP1196642)
License Information

Text and Data Mining valid from 2024-09-27

Version of Record valid from 2024-09-27
More Information

Article History

Received: 26 April 2024

Accepted: 2 September 2024

First Online: 27 September 2024

Declarations

:

: The trial received ethical approval from the Sierra Leone Ethics and Scientific Review Committee (SLESRC) and the Ethics Committee of the Hospital Clinic de Barcelona (EMA/CHMP/ICH/135/1995). Caregivers or legal representative guardians of the participating children in the trial provide written informed consent.

: This manuscript does not contain individual personal data from the trial participants.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below